drugset / Trial / NCT04757974
Low-dose Fostemsavir Extended Release Relative Bioavailability Study
RandomizedCrossoverOpen-labelTreatment
Summary
This is a two-part study. Part 1 will evaluate relative bioavailability of temsavir (TMR) following single dose administration of the reference fostemsavir (FTR) compared to two low-dose ER tablet formulations of FTR. In Part 2, the effect of food on the bioavailability of TMR will be assessed on the selected low-dose ER tablet formulation from Part 1.
Timeline
- Start
- 2021-03-05
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fostemsavir | Other / unclassified | 200 mg | Oral |
| Subject | Fostemsavir | Other / unclassified | 600 mg | Oral |